Biodesix Inc. (BDSX)
Market Open
12 Jun, 16:27
NASDAQ (NMS) NASDAQ (NMS) Primary $
15. 70
+0.9
+6.0811%
$
134.31M Market Cap
- P/E Ratio
- Div Yield
10,842 Volume
-0.42 Eps
$ 14.8
Previous Close Want to track BDSX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biodesix, Inc. (BDSX) Q2 2024 Earnings Call Transcript
Biodesix, Inc. (NASDAQ:BDSX ) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Chris Brinzey - IR Scott Hutton - CEO Robin Harper Cowie - CFO Conference Call Participants Andrew Brackmann - William Blair Thomas Flaten - Lake Street Capital Markets Operator Good day and thank you for standing by. Welcome to the Biodesix Q2 2024 Earnings Conference Call.
Seekingalpha | 1 year ago
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates
Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.17 per share a year ago.
Zacks | 1 year ago
